Literature DB >> 23612973

Phosphorylation of serine 399 in LKB1 protein short form by protein kinase Cζ is required for its nucleocytoplasmic transport and consequent AMP-activated protein kinase (AMPK) activation.

Huaiping Zhu1, Cate M Moriasi1, Miao Zhang1, Yu Zhao1, Ming-Hui Zou2.   

Abstract

Two splice variants of LKB1 exist: LKB1 long form (LKB1(L)) and LKB1 short form (LKB1(S)). In a previous study, we demonstrated that phosphorylation of Ser-428/431 (in LKB1(L)) by protein kinase Cζ (PKCζ) was essential for LKB1-mediated activation of AMP-activated protein kinase (AMPK) in response to oxidants or metformin. Paradoxically, LKB1S also activates AMPK although it lacks Ser-428/431. Thus, we hypothesized that LKB1(S) contained additional phosphorylation sites important in AMPK activation. Truncation analysis and site-directed mutagenesis were used to identify putative PKCζ phosphorylation sites in LKB1(S). Substitution of Ser-399 to alanine did not alter the activity of LKB1(S), but abolished peroxynitrite- and metformin-induced activation of AMPK. Furthermore, the phosphomimetic mutation (S399D) increased the phosphorylation of AMPK and its downstream target phospho-acetyl-coenzyme A carboxylase (ACC). PKCζ-dependent phosphorylation of Ser-399 triggered nucleocytoplasmic translocation of LKB1(S) in response to metformin or peroxynitrite treatment. This effect was ablated by pharmacological and genetic inhibition of PKCζ, by inhibition of CRM1 activity and by substituting Ser-399 with alanine (S399A). Overexpression of PKCζ up-regulated metformin-mediated phosphorylation of both AMPK (Thr-172) and ACC (Ser-79), but the effect was ablated in the S399A mutant. We conclude that, similar to Ser-428/431 (in LKB1(L)), Ser-399 (in LKB1(S)) is a PKCζ-dependent phosphorylation site essential for nucleocytoplasmic export of LKB1(S) and consequent AMPK activation.

Entities:  

Keywords:  AMP-activated Kinase (AMPK); LKB; Metformin; Peroxynitrite; Phosphorylation; Protein Kinase C (PKC); Signal Transduction

Mesh:

Substances:

Year:  2013        PMID: 23612973      PMCID: PMC3675585          DOI: 10.1074/jbc.M112.443580

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo.

Authors:  S P Collins; J L Reoma; D M Gamm; M D Uhler
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.

Authors:  G P Sapkota; A Kieloch; J M Lizcano; S Lain; J S Arthur; M R Williams; N Morrice; M Deak; D R Alessi
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

3.  Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice.

Authors:  A Ylikorkala; D J Rossi; N Korsisaari; K Luukko; K Alitalo; M Henkemeyer; T P Mäkelä
Journal:  Science       Date:  2001-08-17       Impact factor: 47.728

4.  In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours.

Authors:  A Rowan; M Churchman; R Jefferey; A Hanby; R Poulsom; I Tomlinson
Journal:  J Pathol       Date:  2000-10       Impact factor: 7.996

5.  Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1).

Authors:  Marianne Tiainen; Kari Vaahtomeri; Antti Ylikorkala; Tomi P Mäkelä
Journal:  Hum Mol Genet       Date:  2002-06-15       Impact factor: 6.150

6.  Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung.

Authors:  Montserrat Sanchez-Cespedes; Paola Parrella; Manel Esteller; Shuji Nomoto; Barry Trink; James M Engles; William H Westra; James G Herman; David Sidransky
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

Review 7.  Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions.

Authors:  Takaaki Hirai; Kazuhiro Chida
Journal:  J Biochem       Date:  2003-01       Impact factor: 3.387

Review 8.  LKB1; linking cell structure and tumor suppression.

Authors:  A F Hezel; N Bardeesy
Journal:  Oncogene       Date:  2008-11-24       Impact factor: 9.867

9.  Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis.

Authors:  Kou-ichi Jishage; Jun-ichi Nezu; Yosuke Kawase; Takamitsu Iwata; Miho Watanabe; Akio Miyoshi; Asuka Ose; Kiyoshi Habu; Takei Kake; Nobuo Kamada; Otoya Ueda; Michiko Kinoshita; Dieter E Jenne; Miyuki Shimane; Hiroshi Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

10.  LKB1 is an essential regulator of spermatozoa release during spermiation in the mammalian testis.

Authors:  Fiona C Denison; Lee B Smith; Phillip J Muckett; Laura O'Hara; David Carling; Angela Woods
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

View more
  15 in total

Review 1.  PAR3-PAR6-atypical PKC polarity complex proteins in neuronal polarization.

Authors:  Sophie M Hapak; Carla V Rothlin; Sourav Ghosh
Journal:  Cell Mol Life Sci       Date:  2018-04-25       Impact factor: 9.261

2.  Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition.

Authors:  X Li; D Roife; Y Kang; B Dai; M Pratt; J B Fleming
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

Review 3.  Controlling the master-upstream regulation of the tumor suppressor LKB1.

Authors:  Lars Kullmann; Michael P Krahn
Journal:  Oncogene       Date:  2018-03-15       Impact factor: 9.867

4.  Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action.

Authors:  Sookhee Bang; Yong Chen; Rexford S Ahima; Sangwon F Kim
Journal:  Mol Endocrinol       Date:  2014-05-30

5.  Bioactive compounds from Artemisia dracunculus L. activate AMPK signaling in skeletal muscle.

Authors:  B Vandanmagsar; Y Yu; C Simmler; T N Dang; P Kuhn; A Poulev; D M Ribnicky; G F Pauli; Z E Floyd
Journal:  Biomed Pharmacother       Date:  2021-09-23       Impact factor: 6.529

Review 6.  Regulation and function of AMPK in physiology and diseases.

Authors:  Sang-Min Jeon
Journal:  Exp Mol Med       Date:  2016-07-15       Impact factor: 8.718

7.  AMP-activated protein kinase contributes to zinc-induced neuronal death via activation by LKB1 and induction of Bim in mouse cortical cultures.

Authors:  Jae-Won Eom; Jong-Min Lee; Jae-Young Koh; Yang-Hee Kim
Journal:  Mol Brain       Date:  2016-02-09       Impact factor: 4.041

8.  Two PTP receptors mediate CSPG inhibition by convergent and divergent signaling pathways in neurons.

Authors:  Yosuke Ohtake; Daniella Wong; P M Abdul-Muneer; Michael E Selzer; Shuxin Li
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

9.  Conditional knockout of polarity complex (atypical) PKCι reveals an anti-inflammatory function mediated by NF-κB.

Authors:  Radia Forteza; Yolanda Figueroa; Anastasia Mashukova; Vipin Dulam; Pedro J Salas
Journal:  Mol Biol Cell       Date:  2016-05-25       Impact factor: 4.138

10.  Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.

Authors:  Gerald Davies; Liubov Lobanova; Wojciech Dawicki; Gary Groot; John R Gordon; Matthew Bowen; Troy Harkness; Terra Arnason
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.